Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aura Biosciences (AURA) Gains from Sales and Divestitures (2022 - 2026)

Aura Biosciences filings provide 5 years of Gains from Sales and Divestitures readings, the most recent being $500744.0 for Q1 2026.

  • Quarterly Gains from Sales and Divestitures rose 136.46% to $500744.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $500744.0 through Mar 2026, up 136.46% year-over-year, with the annual reading at $532401.0 for FY2025, 71.61% up from the prior year.
  • Gains from Sales and Divestitures hit $500744.0 in Q1 2026 for Aura Biosciences, down from $532401.0 in the prior quarter.
  • Across five years, Gains from Sales and Divestitures topped out at $532401.0 in Q4 2025 and bottomed at $43162.0 in Q4 2023.
  • Average Gains from Sales and Divestitures over 5 years is $253267.9, with a median of $211770.0 recorded in 2025.
  • The largest annual shift saw Gains from Sales and Divestitures fell 16.1% in 2023 before it soared 618.79% in 2024.
  • Aura Biosciences' Gains from Sales and Divestitures stood at $51444.0 in 2022, then decreased by 16.1% to $43162.0 in 2023, then soared by 618.79% to $310245.0 in 2024, then skyrocketed by 71.61% to $532401.0 in 2025, then decreased by 5.95% to $500744.0 in 2026.
  • Per Business Quant, the three most recent readings for AURA's Gains from Sales and Divestitures are $500744.0 (Q1 2026), $532401.0 (Q4 2025), and $379970.0 (Q3 2025).